Biography
Pieter van Baal is a Professor of Public Health Economics. His research focuses on the methodology of cost effectiveness analyses, modeling of diseases/population health and the relation thereof with (non)medical consumption. He has extensive experience in economic evaluations of public health interventions, Markov modeling, uncertainty analyses and is the main developer of PAID (Practical Application to Include future Disease costs).
Pieter has served on the editorial boards of PLoS One, Population Health Metrics and currently is an associate editor of Value of Health.
Erasmus School of Health Policy & Management
Full professor | Health Economics (HE)
- vanbaal@eshpm.eur.nl
- Room
- J8-43
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- Hamraz Mokri, Pieter van Baal & Maureen Rutten-van Mölken (2024) - The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries - European Journal of Health Economics - doi: 10.1007/s10198-024-01690-2 - [link]
- Hamraz Mokri, Pascal R.D. Clephas, Rudolf A. de Boer, Pieter van Baal, Jasper J. Brugts & Maureen P.M.H. Rutten-van Mölken (2024) - Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure in the Netherlands - European Journal of Heart Failure, 26 (5), 1189-1198 - doi: 10.1002/ejhf.3213 - [link]
- Pieter van Baal & Pedro Pita Barros (2024) - Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis - Value in Health, 27 (3), 271-272 - doi: 10.1016/j.jval.2024.01.006 - [link]
- Jawa Issa, Bram Wouterse, Elena Milkovska & Pieter van Baal (2024) - Quantifying income inequality in years of life lost to COVID-19: a prediction model approach using Dutch administrative data - International Journal of Epidemiology, 53 (1) - doi: 10.1093/ije/dyad159 - [link]
- Leona Hakkaart - van Roijen, Stijn Peeters, Tim Kanters, Pieter van Baal, Werner Brouwer, Ruben Drost, Silvia M.A.A. Evers, Job van Exel, Vivian Reckers-Droog, Nasr-Eddine Tannaoui, Frederick Thielen & Ben Wijnen (2024) - <b>Kostenhandleiding </b>voor economische evaluaties in de gezondheidszorg:: Methodologie en Referentieprijzen - [link]
- Elena Milkovska & Pieter HM van Baal (2023) - Health outcomes in Bulgaria: Simulated effects of obesogenic environmental changes in adulthood versus childhood - Preventive Medicine, 175 - doi: 10.1016/j.ypmed.2023.107700 - [link]
- Nilmini Wijemunige, Ravindra P. Rannan-Eliya, Pieter van Baal & Owen O’Donnell (2023) - Optimizing cardiovascular disease risk screening in a low-resource setting: cost-effectiveness of program modifications in Sri Lanka modelled with nationally representative survey data - BMC Public Health, 23 (1) - doi: 10.1186/s12889-023-16640-5 - [link]
- Saskia de Groot, Irene Santi, Pieter Bakx, Bram Wouterse & Pieter van Baal (2023) - Informal care costs according to age and proximity to death to support cost-effectiveness analyses - PharmacoEconomics, 41 (9), 1137-1149 - doi: 10.1007/s40273-022-01233-8 - [link]
- Werner Brouwer & Pieter van Baal (2023) - Moving Forward with Taking a Societal Perspective: A Themed Issue on Productivity Costs, Consumption Costs and Informal Care Costs - PharmacoEconomics, 41 (9), 1027-1030 - doi: 10.1007/s40273-023-01307-1 - [link]
- Martine Hoogendoorn, Milanne Galekop & Pieter van Baal (2023) - The lifetime health and economic burden of obesity in five European countries: what is the potential impact of prevention? - Diabetes, Obesity and Metabolism, 25 (8), 2351-2361 - doi: 10.1111/dom.15116 - [link]
- Hamraz Mokri, Ingelin Kvamme, Linda de Vries, Matthijs Versteegh & Pieter van Baal (2023) - Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries - European Journal of Health Economics, 24 (5), 701-715 - doi: 10.1007/s10198-022-01501-6 - [link]
- Bram Wouterse, Pieter van Baal, Matthijs Versteegh & Werner Brouwer (2023) - The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice - PharmacoEconomics, 41 (6), 607-617 - doi: 10.1007/s40273-023-01265-8 - [link]
- M. Quaife, G. F. Medley, M. Jit, T. Drake, M. Asaria, P. van Baal, R. Baltussen, L. Bollinger, F. Bozzani, O. Brady, H. Broekhuizen, K. Chalkidou, Y. L. Chi, D. W. Dowdy, S. Griffin, H. Haghparast-Bidgoli, T. Hallett, K. Hauck, T. D. Hollingsworth, C. F. McQuaid, N. A. Menzies, M. W. Merritt, A. Mirelman, A. Morton, F. J. Ruiz, M. Siapka, J. Skordis, F. Tediosi, P. Walker, R. G. White, P. Winskill, A. Vassall & G. B. Gomez (2022) - Considering equity in priority setting using transmission models: Recommendations and data needs - Epidemics, 41 - doi: 10.1016/j.epidem.2022.100648 - [link]
- Matthijs Versteegh, Ide van der Helm, Hamraz Mokri, Simone Oerlemans, Hedwig Blommestein & Pieter van Baal (2022) - Estimating Quality of Life Decrements in Oncology Using Time to Death - Value in Health, 25 (10), 1673-1677 - doi: 10.1016/j.jval.2022.06.002 - [link]
- Bram Wouterse, Frederique Ram & Pieter van Baal (2022) - Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands - Value in Health, 25 (5), 731-735 - doi: 10.1016/j.jval.2021.12.008 - [link]
- Megan Perry-Duxbury, James Lomas, Miqdad Asaria & Pieter van Baal (2022) - The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS - PharmacoEconomics, 40 (2), 233-239 - doi: 10.1007/s40273-021-01090-x - [link]
- Muhammad Ashar, Lara Riedige Rohm, Pieter van Baal & Eddy van Doorslaer van Doorslaer (2021) - Improving maternal and child health in Pakistan: a programme evaluation using a difference in difference analysis - BMJ Global Health, 6 (12) - doi: 10.1136/bmjgh-2021-006453 - [link]
- Klas Kellerborg, Bram Wouterse, Werner Brouwer & Pieter van Baal (2021) - Estimating the costs of non-medical consumption in life-years gained for economic evaluations - Social Science and Medicine, 289, 114414 - doi: 10.1016/j.socscimed.2021.114414 - [link]
- Linda De Vries, Marion Koopmans, Alec Morton & Pieter Van Baal (2021) - The economics of improving global infectious disease surveillance - BMJ Global Health, 6 (9) - doi: 10.1136/bmjgh-2021-006597 - [link]
Zorginstituut Nederland
- Start date approval
- November 2023
- End date approval
- August 2026
- Place
- DIEMEN
- Description
- Lid Adviescommissie Pakket (ACP) Zorginstituut
Master Thesis HE
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
